Quantum binding energies of checkpoint CTLA-4 in complex with the immuno-oncological drug ipilimumab

文献信息

发布日期 2021-06-28
DOI 10.1039/D1CP01977E
影响因子 3.676
作者

E. L. Albuquerque


查看原文

摘要

Inhibition of the checkpoint protein CTLA-4 by the US-FDA's approved monoclonal antibody ipilimumab has delivered breakthrough therapies against a wide range of cancers, being an important issue for clinical research. To date, many structural properties of this drug have been unveiled. However, the binding energy features of the receptor CTLA-4 in complex with its drug inhibitor, based on crystallographic data, need a deeper understanding. Within this context, by employing quantum chemistry we investigate in silico the binding energy features of the checkpoint protein CTLA-4 in complex with its drug inhibitor, highlighting the most relevant residue–residue interactions, looking for new insights into the mechanisms of pathway blockade to further engineer its affinity and selectivity. Our computational results not only give a better understanding of the binding mechanisms, but also point to an efficient alternative towards the development of antibody-based drugs, leading to new treatments for cancer therapy based upon immunotherapy.

相关文献

Investigation of the nanomechanical properties of β-Si3N4nanowires under three-point bending via molecular dynamics simulation

Xuefeng Lu, Hongjie Wang, Meng Chen, Lei Fan, Chao Wang, Shuhai Jia

2013-02-27 Communication

DOI: 10.1039/C3CP50372K

Temperature and time dependence on ZnS microstructure and phases obtained through hydrothermal decomposition of diethyldithiocarbamate complexes

Guilherme Oliveira Siqueira, Tulio Matencio, Herculano Vieira da Silva, Yara Gonçalves de Souza, José Domingos Ardisson, Geraldo Magela de Lima, Arilza de Oliveira Porto

2013-03-04 Paper

DOI: 10.1039/C3CP50549A

Changed reactivity of the 1-bromo-4-nitrobenzene radical anion in a room temperature ionic liquid

Sven Ernst, Kristopher R. Ward, Sarah E. Norman, Christopher Hardacre, Richard G. Compton

2013-03-15 Paper

DOI: 10.1039/C3CP51004B

Hydrogen adsorption and desorption at the Pt(110)-(1×2) surface: experimental and theoretical study

Kees-Jan Weststrate, Ludo Juurlink

2013-03-05 Paper

DOI: 10.1039/C3CP44503H

Co–Ni layered double hydroxides for water oxidation in neutral electrolyte

Ye Zhang, Bai Cui, Chunsong Zhao, Hong Lin

2013-03-18 Paper

DOI: 10.1039/C3CP50202C

Impact of short and long-range effects on the magnetic interactions in neutral organic radical-based materials

Alex Domingo, Martin Vérot, Fernando Mota, Juan J. Novoa, Vincent Robert

2013-03-18 Paper

DOI: 10.1039/C3CP44647F

Photoelectrical properties and the electronic structure of Tl1−xIn1−xSnxSe2 (x = 0, 0.1, 0.2, 0.25) single crystalline alloys

G. E. Davydyuk, H. Kamarudin, G. L. Myronchuk, S. P. Danylchuk, A. O. Fedorchuk, L. V. Piskach, M. Yu. Mozolyuk, O. V. Parasyuk

2013-03-12 Paper

DOI: 10.1039/C3CP50836F

Fast phase formation of double-filled p-type skutterudites by ball-milling and hot-pressing

Qing Jie, Hengzhi Wang, Weishu Liu, Hui Wang, Gang Chen, Zhifeng Ren

2013-02-11 Paper

DOI: 10.1039/C3CP50327E

您可能还喜欢

化合物问答

处理2-异丙基-5-羧基-1,3-二氧六环(CAS号:116193-72-7)时应注意哪些实验室安全事项?

处理2-异丙基-5-羧基-1,3-二氧六环时应注意以下安全事项:1. 戴上防护眼镜和手套,避免直接接触皮肤和眼睛。2. 在通风橱中操作,确保空气流通。3. 防止...

116193-72-72-Isopropyl-1,3-diox...
化合物问答

2-Hydroxy-N,N-dimethyl-2-phenylacetamide(CAS号:2019-71-8)的市场或研究趋势如何?

该化合物在制药和精细化工领域具有一定的应用,特别是在药物合成中作为中间体。随着环保意识的提高,市场对更安全、更环保的化学品的需求增加,因此该化合物的研究趋势倾向...

2019-71-82-Hydroxy-N,N-dimeth...
化合物问答

4-(1H-吡唑-3-基)哌啶(CAS号:278798-08-6)应用于哪些行业?

4-(1H-吡唑-3-基)哌啶在医药领域有潜在应用,可用于合成药物中间体。此外,在聚合物和传感器领域也有一定的应用前景,可以作为功能材料的一部分。

278798-08-64-(1H-Pyrazol-3-yl)p...
化合物问答

什么是三氯噻嗪(CAS号:133-67-5)?

三氯噻嗪是一种化学物质,其英文名称为6-Chloro-3-(dichloromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiaz...

133-67-56-Chloro-3-(dichloro...
化合物问答

阿螺旋霉素(CAS号:467214-20-6)通常如何合成?

阿螺旋霉素的合成通常采用生物发酵技术,首先从特定的链霉菌提取前体物质,然后通过一系列化学修饰步骤,如酰胺化、环化等,最终得到阿螺旋霉素。常用的催化剂包括有机酸等...

467214-20-6Alvespimycin Hydroch...
化合物问答

什么是2-(二甲基氨基)-5-硝基苯甲酸(CAS号:4405-28-1)?

2-(二甲基氨基)-5-硝基苯甲酸是一种化学化合物,其分子式为C9H11N2O4。该化合物具有一定的生物活性和化学性质,常用于医药、农药及研究领域。

4405-28-12-(Dimethylamino)-5-...
化合物问答

1-苯基-1H-吡唑-4-甲酸甲酯(CAS号:7188-96-7)应用于哪些行业?

1-苯基-1H-吡唑-4-甲酸甲酯主要应用于医药行业,用作合成其他药物的中间体。此外,它还可能在聚合物、传感器等领域有应用。

7188-96-7Methyl 1-phenyl-1h-p...
化合物问答

1-(三异丙基甲硅烷基氧基)环丙烷羧酸甲酯(CAS号:83010-83-7)应用于哪些行业?

该化合物主要用于有机合成中间体领域,特别是在医药合成中作为关键中间体。它也可用于聚合物合成和传感器材料制备。由于其特殊的环丙烷结构和甲硅烷基氧基团,它在半导体材...

83010-83-77-Methoxy-8-nitroqui...
化合物问答

(+)-蛇菰宁(CAS号:215319-47-4)安全吗?

目前没有明确的毒性数据,但作为天然化合物,它通常被认为相对安全。然而,在操作时应避免直接接触皮肤和眼睛,并确保良好的通风条件。

215319-47-4Balanophonin, (+)-
化合物问答

如何处理含有对甲苯氧基乙酸肼(CAS号:36304-39-9)的废料?

含有对甲苯氧基乙酸肼的废料应首先通过中和或沉淀等方法进行预处理,以降低其毒性。然后,可以采用焚烧或交由专业废物处理公司进行安全处置。根据当地法规和环境标准,务必...

36304-39-92-(4-Methylphenoxy)a...

来源期刊

Physical Chemistry Chemical Physics

Physical Chemistry Chemical Physics
CiteScore: 5.5
自引率: 10.3%
年发文量: 3036

Physical Chemistry Chemical Physics (PCCP) is an international journal co-owned by 19 physical chemistry and physics societies from around the world. This journal publishes original, cutting-edge research in physical chemistry, chemical physics and biophysical chemistry. To be suitable for publication in PCCP, articles must include significant innovation and/or insight into physical chemistry; this is the most important criterion that reviewers and Editors will judge against when evaluating submissions. The journal has a broad scope and welcomes contributions spanning experiment, theory, computation and data science. Topical coverage includes spectroscopy, dynamics, kinetics, statistical mechanics, thermodynamics, electrochemistry, catalysis, surface science, quantum mechanics, quantum computing and machine learning. Interdisciplinary research areas such as polymers and soft matter, materials, nanoscience, energy, surfaces/interfaces, and biophysical chemistry are welcomed if they demonstrate significant innovation and/or insight into physical chemistry. Joined experimental/theoretical studies are particularly appreciated when complementary and based on up-to-date approaches.

推荐化合物

推荐供应商

免责声明
本页面提供的学术期刊信息仅供参考和研究使用。我们与任何期刊出版商均无关联,也不处理投稿事宜。如有投稿相关咨询,请直接联系相关期刊出版商。
如发现页面信息有误,请发送邮件至 support@chemtradehub.com 联系我们。我们将及时核实并处理您的问题。